This Is MS Multiple Sclerosis Knowledge & Support Community

Genzyme's plans to grow its multiple sclerosis business in Europe continued with the launch of two new treatments in the Republic of Ireland.

The company, which serves as the biotech arm of French pharma firm Sanofi, today launched the injectable Lemtrada (alemtuzumab) in the country just weeks after oral multiple sclerosis (MS) treatment Aubagio (teriflunomide) hit the market...... Read More - http://www.ms-uk.org/lemtrada

Have to love it. One of the ms specialists i talked to is involved in a lot of trials and has been for a few decades. Said lemtrada was the only drug she had seen that actually helped people and now she cant use it. The fact i can get on a plane and fly literally in any direction and get it, hell drive 2 of them, but cant get it where i have "cadillac" insurance (in other words insurance that is actually useable) boggles the mind.

Squiffy, you have made a mistake: lemtrada is not injectable: it is an infusion.
Sarah

I think that it has opened up a new window in the life of people having multiple sclerosis. Whenever, I read this news, I really very happy. Researchers are always ready to invent the new things.